Australia, Jan. 8 -- Progentos Therapeutics Inc., owns the trademark (2491023) for 'PROGENTOS THERAPEUTICS' till Aug. 12, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations used to treat diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders.] and 42 [Medical and scientific research and development in the field of diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders.]
Type of Mark: Word
Date of Acceptance: Oct. 21, 2024
Registration Advertised: Jan. 7
For further details contact Monica Riva Talley Sterne, Kessler, Goldstein & Fox P L.L.C .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2491023.
Disclaimer: Curated by HT Syndication.
